KAHR Medical Raises $18 Million in Private Funding Round
JERUSALEM, Feb 26, 2020 /PRNewswire-AsiaNet/ -- Funds will be used for advancing the Company's next generation immuno-oncology drug candidates, including lead anti-CD47 product for the treatment of solid tumors through Phase I/II study in addition to advancing preclinical pipelineKAHR Medic...
Authors: LATEST ASIANET NEWS RELEASES